{"id":"W2135996840","doi":"10.1016/s1665-2681(19)31482-6","title":"Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients( )","year":2012,"lang":"en","type":"article","venue":"Annals of Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health; University of Florida","keywords":"Medicine; Ribavirin; Internal medicine; Adverse effect; Gastroenterology; Peginterferon alfa-2a; Regimen; Neutropenia; Randomized controlled trial; Sofosbuvir; Hepatitis C virus; Immunology; Virus; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001921036,0.0002604231,0.002183101,0.0006053206,0.00002747668,0.00000487233,0.0002404299,0.0003132628,0.0006749041],"category_scores_gemma":[0.002666577,0.000228814,0.0004095631,0.0003610443,0.0004932436,0.0001728798,0.0001614474,0.0003860161,0.000109229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007840886,"about_ca_system_score_gemma":0.0003249074,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005556207,"about_ca_topic_score_gemma":0.0006551479,"domain_scores_codex":[0.9958941,0.00103185,0.001374368,0.0003182181,0.0005642525,0.0008172287],"domain_scores_gemma":[0.9975693,0.0007387379,0.0003999716,0.0005521811,0.000474228,0.0002655862],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4887932,0.001333426,0.4929579,0.0001936771,0.000232305,0.00003045772,0.0008039483,0.000001349825,0.0003262502,0.0009641087,0.002391003,0.01197237],"study_design_scores_gemma":[0.9255933,0.003444679,0.04819567,0.0002073445,0.0001300349,0.00001556059,0.00003717625,0.0006656988,0.01010858,0.0003622131,0.01090859,0.0003311918],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886715,0.001229409,0.00005847424,0.001160413,0.0004555153,0.001937244,0.00004241081,0.00002354465,0.006421506],"genre_scores_gemma":[0.9964768,0.002193185,0.000213562,0.0005131183,0.0001258987,0.0001548172,0.00008020778,0.00004116634,0.0002012411],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4447622,"threshold_uncertainty_score":0.9330765,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07966483117321732,"score_gpt":0.3849926111109822,"score_spread":0.3053277799377649,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}